Response to gabapentin enacarbil in two groups of RLS patients: Previously exposed to long-term treatment with dopaminergic agents versus dopaminergic treatment-naive patients.
Phase of Trial: Phase IV
Latest Information Update: 13 Mar 2018
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- 13 Mar 2018 Last checked against European Clinical Trials Database.
- 09 Mar 2018 Status changed from recruiting to completed.
- 21 Jul 2015 New trial record